Literature DB >> 16330937

Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.

Gladell P Paner1, John R Srigley, Anuradha Radhakrishnan, Cynthia Cohen, Brian F Skinnider, Satish K Tickoo, Andrew N Young, Mahul B Amin.   

Abstract

Mucinous tubular and spindle cell carcinoma, a rare, recently described distinctive subtype of renal cell carcinoma, may have some morphologic similarities to the more common papillary renal cell carcinoma, particularly the basophilic (type 1) tumors with prominent solid growth pattern. Tumor circumscription, compact tubular architecture, focal papillations, mucin production and foam cells (features seen in both papillary renal cell carcinoma and mucinous tubular and spindle cell carcinoma), as well as spindle cell morphology, have resulted in some cases sent to us in consultation with a question of possible sarcomatoid papillary renal cell carcinoma. In this study, tissue microarrays with triplicate samples each from 27 mucinous tubular and spindle cell carcinomas and 20 papillary renal cell carcinomas were created to simulate experience in renal biopsy specimens. From immunohistochemistry (IHC) data, published in the contemporary literature, a panel consisting of alpha-methylacyl-CoA racemase (AMACR), cytokeratin 7 (CK7), epithelial membrane antigen (EMA), renal cell carcinoma marker (RCC Ma), CD10, high molecular weight cytokeratin (HMWK), and c-kit was designed to test its utility in differential diagnosis. The immunoreactivity in mucinous tubular and spindle cell carcinoma was AMACR 93%, CK7 81%, EMA 95%, RCC Ma 7%, CD10 15%, HMWK 15%, and c-kit 5% and in papillary renal cell carcinoma was AMACR 95%, CK7 65%, EMA 88%, RCC Ma 25%, CD10 80%, HWMK 15%, and c-kit 18%. This largest study to date on IHC of mucinous tubular and spindle cell carcinoma dispels the specificity of AMACR for papillary renal cell carcinoma among the RCC subtypes. The histogenesis of mucinous tubular and spindle cell carcinoma from the distal nephron continues to be debatable, as our study showed the expression of the proximal convoluted tubule-related marker AMACR among these tumors. Thus, in tumors with predominant compact tubular growth and focal papillary architectures, careful attention to the presence of a low-grade spindle cell population may be helpful in the distinction of mucinous tubular and spindle cell carcinoma, as the key immunohistochemical stains for papillary renal cell carcinoma are also expressed in this subtype of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16330937     DOI: 10.1097/01.pas.0000180443.94645.50

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  38 in total

Review 1.  Mucinous tubular and spindle cell carcinoma of the kidney: the contrast-enhanced ultrasonography and CT features of six cases and review of the literature.

Authors:  Qing Zhang; Wei Wang; Shiwei Zhang; Xiaozhi Zhao; Shun Zhang; Guangxiang Liu; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2014-08-27       Impact factor: 2.370

2.  A case of acquired renal cystic disease (ACDK) with oncocytosis, a dominant nodule (oncocytoma), multiple adenomas and a microscopic papillary renal cell carcinoma associated with crescentic glomerulonephritis.

Authors:  C L Menéndez; A Pobes; M G Corte Torres; E Fuente; A M Merino; B Corrales; M Argüelles
Journal:  Virchows Arch       Date:  2006-11-17       Impact factor: 4.064

3.  Renal cell carcinoma with t(X;17)(p11.2;q25) in a 5-year-old Taiwanese boy: a case report and review of the literature.

Authors:  Chih-Jung Chen; Hui-Ting Hsu; Ming-Tsan Lin; Mariann Pintye; Jim-Ray Chen
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

4.  Clear cell changes in mucinous tubular and spindle cell carcinoma: cytoplasmic pallor/clearing within tubules, vacuoles or hybrid conventional clear cell carcinoma of kidney?

Authors:  Wanli Cao; Baoxing Huang; Xiaochun Fei; Xin Huang; Jun Dai; Wenlong Zhou; Zhaoping Xu; Hengchuan Su; Kang Cheng; Fukang Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Authors:  Jocelyn Stewart; Neil Fleshner; Heather Cole; Joan Sweet
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

6.  CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review.

Authors:  F Cornelis; D Ambrosetti; L Rocher; L E Derchi; B Renard; P Puech; M Claudon; O Rouvière; S Ferlicot; C Roy; M Yacoub; N Grenier; J C Bernhard
Journal:  Eur Radiol       Date:  2016-06-22       Impact factor: 5.315

7.  VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Authors:  Lisha Wang; Yuping Zhang; Ying-Bei Chen; Stephanie L Skala; Hikmat A Al-Ahmadie; Xiaoming Wang; Xuhong Cao; Brendan A Veeneman; Jin Chen; Marcin Cieślik; Yuanyuan Qiao; Fengyun Su; Pankaj Vats; Javed Siddiqui; Hong Xiao; Evita T Sadimin; Jonathan I Epstein; Ming Zhou; Ankur R Sangoi; Kiril Trpkov; Adeboye O Osunkoya; Giovanna A Giannico; Jesse K McKenney; Pedram Argani; Satish K Tickoo; Victor E Reuter; Arul M Chinnaiyan; Saravana M Dhanasekaran; Rohit Mehra
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

8.  Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation.

Authors:  Rochelle A Simon; P Anthony di Sant'agnese; Ganesh S Palapattu; Eric A Singer; Grace D Candelario; Jiaoti Huang; Jorge L Yao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 9.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337

Review 10.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.